PubRank

Johan H J M van Krieken

Author PubWeight™ 33.86‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Chemotherapy, bevacizumab, and cetuximab in metastatic colorectal cancer. N Engl J Med 2009 11.63
2 Platinum-based drugs disrupt STAT6-mediated suppression of immune responses against cancer in humans and mice. J Clin Invest 2011 1.91
3 Gene expression profiling in follicular lymphoma to assess clinical aggressiveness and to guide the choice of treatment. Blood 2004 1.56
4 The origin of epithelial neoplasms after allogeneic stem cell transplantation. Haematologica 2006 1.39
5 Lymph node retrieval in rectal cancer is dependent on many factors--the role of the tumor, the patient, the surgeon, the radiotherapist, and the pathologist. Am J Surg Pathol 2009 1.29
6 Correlation of FCGR3A and EGFR germline polymorphisms with the efficacy of cetuximab in KRAS wild-type metastatic colorectal cancer. Eur J Cancer 2010 1.17
7 Immunohistochemical profiling of caspase signaling pathways predicts clinical response to chemotherapy in primary nodal diffuse large B-cell lymphomas. Blood 2004 1.08
8 Quantitative microsatellite analysis to delineate the commonly deleted region 1p22.3 in mantle cell lymphomas. Genes Chromosomes Cancer 2006 1.04
9 Novel chromosomal imbalances in mantle cell lymphoma detected by genome-wide array-based comparative genomic hybridization. Blood 2004 1.04
10 Pitfalls in TCR gene clonality testing: teaching cases. J Hematop 2008 1.03
11 Mutation analysis of KRAS prior to targeted therapy in colorectal cancer: development and evaluation of quality by a European external quality assessment scheme. Virchows Arch 2011 1.03
12 Preparing pathology for personalized medicine: possibilities for improvement of the pre-analytical phase. Histopathology 2011 0.97
13 Prognostic significance of metallothionein in human gastrointestinal cancer. Clin Cancer Res 2002 0.96
14 Promoter methylation of PARG1, a novel candidate tumor suppressor gene in mantle-cell lymphomas. Haematologica 2007 0.92
15 Protein profiling of B-cell lymphomas using tissue biopsies: A potential tool for small samples in pathology. Cell Oncol 2008 0.89
16 Integrated genomic and expression profiling in mantle cell lymphoma: identification of gene-dosage regulated candidate genes. Br J Haematol 2008 0.88
17 Application of microfluidic technology to the BIOMED-2 protocol for detection of B-cell clonality. J Mol Diagn 2011 0.86
18 Hypermutation in mantle cell lymphoma does not indicate a clinical or biological subentity. Mod Pathol 2009 0.83
19 Transgenic mice with mammary gland targeted expression of human cortactin do not develop (pre-malignant) breast tumors: studies in MMTV-cortactin and MMTV-cortactin/-cyclin D1 bitransgenic mice. BMC Cancer 2006 0.83
20 Improvement of hospital care for patients with non-Hodgkin's lymphoma: protocol for a cluster randomized controlled trial (PEARL study). Implement Sci 2013 0.81
21 High-resolution genomic profiling of pediatric lymphoblastic lymphomas reveals subtle differences with pediatric acute lymphoblastic leukemias in the B-lineage. Cancer Genet Cytogenet 2009 0.80
22 Initial spontaneous remission of posttransplantation Epstein Barr virus-related B-cell lymphoproliferative disorder of the skin in a renal transplant recipient: case report and review of the literature on cutaneous B-cell posttransplantation lymphoproliferative disease. Am J Dermatopathol 2002 0.78
23 Protein profiling in pathology: analysis and evaluation of 239 frozen tissue biopsies for diagnosis of B-cell lymphomas. Proteomics Clin Appl 2010 0.78
24 Treatment and survival of patients with thyroid lymphoma: a population-based study with clinical and pathologic reviews. Clin Lymphoma Myeloma 2005 0.75